Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,783.85
-19.25 (-1.07%)
At close: Jul 17, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 338.08 billion as of July 17, 2026. Its market cap has increased by 30.93% in one year.
Market Cap
338.08B
Enterprise Value
352.08B
Revenue
92.04B
Ranking
n/a
PE Ratio
36.57
Stock Price
1,783.85
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 338.08B, an increase of 31.57%. That is a compound annual growth rate of 14.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 338.08B | 30.70% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 1.01T |
| Abbott India | 595.27B |
| GlaxoSmithKline Pharmaceuticals | 415.90B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 237.17B |
| Granules India | 218.09B |
| AstraZeneca Pharma India | 200.65B |
| Caplin Point Laboratories | 198.69B |